INOVIQ and Promega announced a joint marketing agreement aimed at co-marketing INOVIQ's EXO-NET exosome capture technology and Promega's Nucleic Acid purification systems on a global scale. Together, INOVIQ and Promega will provide researchers, pharmaceutical companies, and clinical diagnostic labs with innovative solutions for exosome isolation, biomarker discovery, and diagnostics research. Under the agreement, customers worldwide will have access to a comprehensive range of Promega manual and automated nucleic acid extraction reagents and instruments, which will be combined with INOVIQ's EXO-NET exosome capture tools. This combination of technologies will enable efficient exosome isolation and facilitate biomarker discovery and diagnostics research. This agreement combines the expertise of global biotechnology leader Promega in the creation, production and marketing of an extensive range of research tools, technologies and automation solutions, with INOVIQ
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!